About Bon Natural Life Limited
https://www.bnlus.comBon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally.
CEO
Yongwei Hu
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-05-19 | Reverse | 1:25 |
| 2024-04-11 | Reverse | 1:10 |
Ratings Snapshot
Rating : B+
Price Target
About Bon Natural Life Limited
https://www.bnlus.comBon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $7.95M ▼ | $1.62M ▼ | $169.23K ▼ | 2.13% ▼ | $0.56 ▲ | $1.2M ▼ |
| Q4-2024 | $13.66M ▲ | $2.35M ▼ | $408.69K ▲ | 2.99% ▲ | $0.23 ▲ | $1.3M ▲ |
| Q2-2024 | $10.18M ▼ | $2.88M ▲ | $-10.52K ▼ | -0.1% ▼ | $-0.01 ▼ | $770.54K ▼ |
| Q4-2023 | $15.37M ▲ | $1.19M ▼ | $2.48M ▲ | 16.11% ▲ | $2.64 ▲ | $3.61M ▲ |
| Q2-2023 | $14.15M | $1.73M | $2.12M | 14.98% | $2.38 | $3.19M |
What's going well?
The company stayed barely profitable despite a tough quarter. R&D and operating costs were cut sharply, helping to limit losses.
What's concerning?
Revenue and profits both fell hard, margins are shrinking, and the company issued a lot more shares, diluting existing shareholders. High taxes and interest costs are also eating into already thin profits.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $8.89M ▲ | $71.58M ▲ | $17.68M ▲ | $53.52M ▲ |
| Q4-2024 | $80.47K ▼ | $61.77M ▲ | $17.42M ▲ | $43.91M ▲ |
| Q2-2024 | $717.88K ▲ | $50.08M ▲ | $12.76M ▲ | $36.69M ▲ |
| Q4-2023 | $112.82K ▼ | $46.56M ▼ | $10.57M ▼ | $35.48M ▲ |
| Q2-2023 | $542.27K | $47.21M | $11.71M | $34.99M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $169.23K ▼ | $-4.3M ▲ | $4.39K ▲ | $12.32M ▲ | $8.24M ▲ | $-4.3M ▲ |
| Q4-2024 | $428.2K ▲ | $-5.84M ▼ | $-15.03K ▼ | $6.24M ▲ | $-60.67K ▼ | $-5.84M ▼ |
| Q2-2024 | $-10.52K ▼ | $-1.88M ▼ | $-694 ▲ | $2.51M ▲ | $605.13K ▲ | $-1.88M ▼ |
| Q4-2023 | $2.48M ▲ | $1.53M ▲ | $-1.17M ▼ | $-759.67K ▼ | $-429.52K ▼ | $1.02M ▲ |
| Q2-2023 | $2.12M | $-2.18M | $-18.1K | $1.91M | $-298.59K | $-2.2M |
CEO
Yongwei Hu
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-05-19 | Reverse | 1:25 |
| 2024-04-11 | Reverse | 1:10 |
Ratings Snapshot
Rating : B+